Travere Therapeutics (TVTX) EPS (Basic) Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.14 Bn | 4.06 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.06% |
| Dec 31, 2025 | 36.23% |
| Sep 30, 2025 | 21.60% |
| Jun 30, 2025 | 24.74% |
| Mar 31, 2025 | -91.12% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 3.81% |
| Jun 30, 2024 | 0.22% |
| Mar 31, 2024 | -12.20% |
| Dec 31, 2023 | -45.65% |
| Sep 30, 2023 | 28.25% |
| Jun 30, 2023 | -19.06% |
| Mar 31, 2023 | -22.52% |
| Dec 31, 2022 | -18.01% |
| Sep 30, 2022 | -18.83% |
| Jun 30, 2022 | -29.74% |
| Mar 31, 2022 | -32.85% |
| Dec 31, 2021 | -44.72% |
| Sep 30, 2021 | 10.01% |
| Jun 30, 2021 | -11.58% |
| Mar 31, 2021 | -38.50% |
| Dec 31, 2020 | -102.27% |
| Sep 30, 2020 | -16.53% |
| Jun 30, 2020 | 4.50% |
| Mar 31, 2020 | -57.60% |
| Dec 31, 2019 | 8.64% |
| Sep 30, 2019 | -4.87% |
| Jun 30, 2019 | -31.95% |
| Mar 31, 2019 | 21.16% |
| Dec 31, 2018 | 24.42% |
| Sep 30, 2018 | -11.43% |
| Jun 30, 2018 | -5.92% |
| Mar 31, 2018 | -0.89% |